Certificate of Advanced Studies in General Management: Certified Board Member (Business Administration and Management, General)
2022 - 2023
USI Università della Svizzera italiana
BioBusiness - Advanced short program on BioEntrepreneurship (Entrepreneurship/Entrepreneurial Studies)
2018 - 2018
University of Bern
CAS Entrepreneurial Leadership (Business Administration and Management, General)
2017 - 2018
California Institute of Technology
Postdoc (Organic Synthesis)
1996 - 1997
Universität Basel
PhD (Organic Synthesis)
1991 - 1996
Eidgenössische Technische Hochschule Zürich
Master (Organic Chemistry / Biochemistry)
1986 - 1991
Guido Koch's Skills
Research Project Management
Research Project
Drug Design
Combinatorial Chemistry
Medizinische Chemie
Project Portfolio
CRO
University Relations
Chemistry
Organic Synthesis
Guido Koch's Summary
Guido Koch, based in Basel, BS, CH, is currently a Co-Founder and CEO at Amphilix, bringing experience from previous roles at Synple, TOPADUR PHARMA AG, Novartis Institutes for BioMedical Research (NIBR) and Novartis. Guido Koch holds a 2022 - 2023 Certificate of Advanced Studies in General Management: Certified Board Member in Business Administration and Management, General @ Rochester-Bern Executive Programs. With a robust skill set that includes Research Project Management, Research Project, Drug Design, Combinatorial Chemistry, Medizinische Chemie and more, Guido Koch contributes valuable insights to the industry. Guido Koch has 4 emails and 3 mobile phone numbers on RocketReach.